Overview
Hypothyroidism due to deficient transcription factors involved in pituitary development or function is a group of rare genetic disorders in which mutations in transcription factors essential for the normal development or function of the pituitary gland lead to insufficient production of thyroid-stimulating hormone (TSH), resulting in central (secondary) hypothyroidism. The pituitary gland, located at the base of the brain, normally produces TSH to stimulate the thyroid gland to release thyroid hormones. When transcription factors such as POU1F1 (PIT1), PROP1, HESX1, LHX3, LHX4, SOX3, or OTX2 are defective, the pituitary may fail to develop properly or may not produce adequate amounts of TSH and often other pituitary hormones. This condition is also referred to as central congenital hypothyroidism due to pituitary transcription factor deficiency and falls under the broader category of combined pituitary hormone deficiency (CPHD) when multiple hormone axes are affected. Clinical features typically present in the neonatal or infantile period and may include poor growth, developmental delay, fatigue, cold intolerance, constipation, prolonged jaundice, and feeding difficulties. Because multiple pituitary hormones are often affected, patients may also exhibit growth hormone deficiency (leading to short stature), gonadotropin deficiency (causing delayed or absent puberty), and adrenocorticotropic hormone deficiency (potentially life-threatening adrenal insufficiency). Some transcription factor defects are associated with structural brain anomalies such as septo-optic dysplasia or pituitary hypoplasia visible on MRI. Early diagnosis through newborn screening and hormonal evaluation is critical. Treatment involves lifelong hormone replacement therapy, primarily with levothyroxine to correct hypothyroidism. Additional hormone replacements—including growth hormone, hydrocortisone, and sex steroids—are administered as needed depending on which pituitary hormone deficiencies are present. With appropriate and timely treatment, many patients can achieve near-normal growth and development, though regular endocrine monitoring throughout life is essential to adjust therapy and detect evolving hormone deficiencies.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hypothyroidism due to deficient transcription factors involved in pituitary development or function at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
Community
No community posts yet. Be the first to share your experience with Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
Start the conversation →Latest news about Hypothyroidism due to deficient transcription factors involved in pituitary development or function
No recent news articles for Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hypothyroidism due to deficient transcription factors involved in pituitary development or function
What is Hypothyroidism due to deficient transcription factors involved in pituitary development or function?
Hypothyroidism due to deficient transcription factors involved in pituitary development or function is a group of rare genetic disorders in which mutations in transcription factors essential for the normal development or function of the pituitary gland lead to insufficient production of thyroid-stimulating hormone (TSH), resulting in central (secondary) hypothyroidism. The pituitary gland, located at the base of the brain, normally produces TSH to stimulate the thyroid gland to release thyroid hormones. When transcription factors such as POU1F1 (PIT1), PROP1, HESX1, LHX3, LHX4, SOX3, or OTX2 a
At what age does Hypothyroidism due to deficient transcription factors involved in pituitary development or function typically begin?
Typical onset of Hypothyroidism due to deficient transcription factors involved in pituitary development or function is neonatal. Age of onset can vary across affected individuals.